Page 506 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 506

17  Male Genital Tract   491


             •	  Sertoli cells are present, but there is no spermatogenesis.
             •	  Leydig cells are prominent.


             Q.  Classify  testicular  tumours.  Describe  their  clinicopathological
             features.
             Ans.	  Testicular tumours are classified based on their origin.
             Classification	of	Testicular	Tumours
             1.  Germ	cell	tumours
                (a)  Seminomatous tumours
                    (i)  Classical semi as noma
                   (ii)  Spermatocytic seminoma
                (b)  Nonseminomatous tumours
                    (i)  Yolk sac tumour
                    (ii)  Choriocarcinoma
                   (iii)  Embryonal carcinoma
                   (iv)  Germ  cell  tumours  with  multiple  histological  patterns,  eg,  embryonal
                       carcinoma with teratoma and choriocarcinoma with others
                (c)  Teratoma
             2.  Sex	cord-stromal	tumours
                (a)  Sertoli cell tumours
                (b)  Leydig cell tumours

             Clinicopathological Features of Testicular Tumours

             •	 All testicular tumours are derived from totipotent germ cells, which can show progressive
               and  retrogressive  differentiation;  therefore,  metastatic  tumours  may  sometimes  show
               a  different  histology  as  compared  to  the  primary  lesion,  eg,  an  embryonal  carcinoma
               presents as a teratoma in the metastatic lesion.
             •	  Most testicular tumours are derived from intratubular germ cell neoplasia (ITGCN),
               which is also commonly seen in their vicinity. Exceptions are paediatric yolk sac tumour,
               teratomas and spermatocytic seminoma. ITGCN is found to be present as early as intra-
               uterine  life.  It  remains  innocuous  till  puberty  when  it  progresses  to  seminomatous
               (SGCT)  or nonseminomatous	tumours	(NSGCT)  subsequent to activating mutations,
               eg, reduplication of the short arm of chromosome 12 and kit activation. ITGCN is his-
               tologically characterized by presence of atypical primordial cells with large pleomorphic
               nuclei and clear cytoplasm.
             •	  Germ cell tumours present as painless enlargement of testes. Their segregation into two
               categories (SGCTs and NSGCTs) is based on their different clinical behaviour.
             •	 Biopsy of a testicular mass is associated with a risk of tumour spillage; therefore, any
               testicular mass is considered neoplastic unless proven otherwise and radical orchiectomy
               is performed based on this assumption.
             •	  Lymphatic spread is common; retroperitoneal paraaortic lymph nodes are the first to be
               involved followed by mediastinal and supraclavicular lymph nodes.
             •	  Haematogenous spread commonly involves lungs, liver, brain and bone.
             •	 Germ cell tumours secrete polypeptide hormones and certain enzymes that can be detected
               in the blood, eg, AFP (a-fetoprotein), HCG (human chorionic gonadotrophins), PLAP (pla-
               cental alkaline phosphatase), placental lactogen and LDH (lactate dehydrogenase).
             •	  These hormones are useful in:
               •	  Diagnosis and staging of testicular germ cell tumours
               •	  Monitoring response to therapy
             •	 Elevated levels of HCG and AFP are most often associated with NSGCTs (marked elevation
               is seen in yolk sac tumour and choriocarcinoma).
             •	 Non-Hodgkin lymphoma is the most common testicular tumour after the fifth decade.
             •	  Staging of testicular germ cell tumours:
                 -	 Stage I: Tumours confined to testis, epididymis or spermatic cord



                                  mebooksfree.com
   501   502   503   504   505   506   507   508   509   510   511